Top Markets
Coin of the day
Meribank Biotech Co., Ltd Meribank Biotech Co., Ltd

Meribank Biotech Co., Ltd

4724
Rank in Stocks #28402
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei... Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
Share Price
$0.2779235
Last synced: 2026-08-19
Market Cap
$26.67M
Change (1 day)
1.39%
Change (1 year)
-50.33%
Country
TW
Trade Meribank Biotech Co., Ltd (4724)

Category

Operating Margin for Meribank Biotech Co., Ltd (4724)
Operating Margin as of 2026 TTM: 0.00%
According to Meribank Biotech Co., Ltd latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Meribank Biotech Co., Ltd from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
-149.01% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.